{"AllianceGenome": "6515", "HGNC": "6515", "MIM": "604861", "_id": "26524", "_version": 1, "accession": {"genomic": ["AL161613.23", "AL356285.9", "CH471075.1", "CP068265.2", "KT585116.1", "NC_000013.11", "NC_060937.1"], "protein": ["AAF80561.1", "BAA92381.1", "BAD93134.1", "BAG36905.1", "EAX08286.1", "EAX08287.1", "NP_055387.2", "Q9NRM7.2", "XP_005266399.1", "XP_011533344.1", "XP_016876030.1", "XP_016876031.1", "XP_047286222.1", "XP_047286223.1", "XP_054230417.1", "XP_054230418.1", "XP_054230419.1", "XP_054230420.1", "XP_054230421.1", "XP_054230422.1", "XP_054230423.1"], "rna": ["AB028019.1", "AB209897.1", "AF207547.1", "AK123520.1", "AK314235.1", "BC036437.1", "BC071572.1", "BC127671.1", "BQ774580.1", "DB452765.1", "NM_014572.3", "XM_005266342.1", "XM_011535042.3", "XM_017020541.2", "XM_017020542.2", "XM_047430266.1", "XM_047430267.1", "XM_054374442.1", "XM_054374443.1", "XM_054374444.1", "XM_054374445.1", "XM_054374446.1", "XM_054374447.1", "XM_054374448.1"], "translation": [{"protein": "BAA92381.1", "rna": "AB028019.1"}, {"protein": "XP_054230423.1", "rna": "XM_054374448.1"}, {"protein": "XP_005266399.1", "rna": "XM_005266342.1"}, {"protein": "NP_055387.2", "rna": "NM_014572.3"}, {"protein": "XP_054230418.1", "rna": "XM_054374443.1"}, {"protein": "XP_047286222.1", "rna": "XM_047430266.1"}, {"protein": "XP_047286223.1", "rna": "XM_047430267.1"}, {"protein": "XP_011533344.1", "rna": "XM_011535042.3"}, {"protein": "XP_016876030.1", "rna": "XM_017020541.2"}, {"protein": "XP_054230419.1", "rna": "XM_054374444.1"}, {"protein": "XP_054230422.1", "rna": "XM_054374447.1"}, {"protein": "XP_054230420.1", "rna": "XM_054374445.1"}, {"protein": "AAF80561.1", "rna": "AF207547.1"}, {"protein": "XP_054230417.1", "rna": "XM_054374442.1"}, {"protein": "BAG36905.1", "rna": "AK314235.1"}, {"protein": "XP_054230421.1", "rna": "XM_054374446.1"}, {"protein": "BAD93134.1", "rna": "AB209897.1"}, {"protein": "XP_016876031.1", "rna": "XM_017020542.2"}]}, "alias": "KPM", "ec": "2.7.11.1", "ensembl": {"gene": "ENSG00000150457", "protein": "ENSP00000372035", "transcript": ["ENST00000382592", "ENST00000472754"], "translation": [{"protein": "ENSP00000372035", "rna": "ENST00000382592"}], "type_of_gene": "protein_coding"}, "entrezgene": "26524", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 23.9739216253, "exp_mis": 468.622018692, "exp_syn": 255.533832721, "lof_z": 4.04094973482645, "mis_z": 3.71957208386453, "mu_lof": 1.95399623215e-06, "mu_mis": 4.39645600107e-05, "mu_syn": 2.40169188462e-05, "n_lof": 4.0, "n_mis": 304.0, "n_syn": 202.0, "p_li": 0.869216004378958, "p_null": 3.09904936910725e-06, "p_rec": 0.130780896571673, "syn_z": 2.07612433969807}, "bp": 3267, "cds_end": 21620165, "cds_start": 21549008, "n_exons": 7, "nonpsych": {"exp_lof": 21.5609810036, "exp_mis": 424.010429076, "exp_syn": 231.145010982, "lof_z": 3.9257136322986, "mis_z": 3.7969445648092, "mu_lof": 1.95399623215e-06, "mu_mis": 4.39645600107e-05, "mu_syn": 2.40169188462e-05, "n_lof": 3.0, "n_mis": 269.0, "n_syn": 184.0, "p_li": 0.941385419864031, "p_null": 2.35804524059064e-06, "p_rec": 0.058612222090728, "syn_z": 1.95234644229367}, "nontcga": {"exp_lof": 22.042583876, "exp_mis": 431.118864279, "exp_syn": 235.077676508, "lof_z": 3.79095568675109, "mis_z": 3.93794637469449, "mu_lof": 1.95399623215e-06, "mu_mis": 4.39645600107e-05, "mu_syn": 2.40169188462e-05, "n_lof": 4.0, "n_mis": 267.0, "n_syn": 184.0, "p_li": 0.770730723720253, "p_null": 1.44256406788931e-05, "p_rec": 0.229254850639068, "syn_z": 2.10934678331114}, "transcript": "ENST00000382592.4"}, "exons": [{"cdsend": 21046026, "cdsstart": 20974869, "chr": "13", "position": [[20973035, 20975364], [20979690, 20979797], [20981465, 20981648], [20983223, 20983806], [20987880, 20989304], [20991271, 20991404], [21045684, 21046230], [21061345, 21061586]], "strand": -1, "transcript": "NM_014572", "txend": 21061586, "txstart": 20973035}], "exons_hg19": [{"cdsend": 21620165, "cdsstart": 21549008, "chr": "13", "position": [[21547175, 21549503], [21553829, 21553936], [21555604, 21555787], [21557362, 21557945], [21562019, 21563443], [21565410, 21565543], [21619823, 21620369], [21635484, 21635725]], "strand": -1, "transcript": "NM_014572", "txend": 21635725, "txstart": 21547175}], "generif": [{"pubmed": 12853976, "text": "of mammalian Lats2 and Lats1 control cell proliferation by negatively regulating different cell cycle check points."}, {"pubmed": 15131260, "text": "LATS2 may play a role in androgen receptor-mediated transcription and contribute to the development of prostate cancer"}, {"pubmed": 15147269, "text": "S83 of Lats2 is a phosphorylation target of Aurora-A and this phosphorylation plays a role of the centrosomal localization of Lats2"}, {"pubmed": 15265683, "text": "Lats2 induces apoptosis through downregulating anti-apoptotic proteins, BCL-2 and BCL-x(L), in human lung cancer cells."}, {"pubmed": 15688006, "text": "Mst2, a STE20-family member and purported Hpo ortholog, phosphorylates and activates both Lats1 and Lats2"}, {"pubmed": 15746036, "text": "Hypermethylation of the promoter region of LATS2 likely plays an important role in the down-regulation of LATS2 mRNA level in breast cancers, and breast cancers with a decreased expression of LATS2 mRNA level have a biologically aggressive phenotype."}, {"pubmed": 17049657, "text": "LATS1 and LATS2 mRNA was down-regulated in astrocytoma by hypermethylation of the promoter"}, {"pubmed": 18565851, "text": "Kpm/Lats2 is involved in the fate of p73 through the phosphorylation of YAP2 by Kpm/Lats2 and the induction of p73 target genes that underlie chemosensitivity of leukemic cells."}, {"pubmed": 18927464, "text": "Lats2 affects both growth and death of cardiac myocytes, but it primarily regulates the size of the heart and acts as an endogenous negative regulator of cardiac hypertrophy."}, {"pubmed": 19008013, "text": "tumor-specific mutations and down-regulation of the gene expression is observed in non-small cell lung carcinoma patients"}, {"pubmed": 19501585, "text": "Data show that LATS2 protein expression is mediated by miR-373 at the post-transcriptional level and inversely correlates with miR-373 amounts in esophageal cancer cell lines."}, {"pubmed": 19799973, "text": "collection of genes identified suggests that LATS1/2 function through diverse mechanisms and multiple signaling pathways including the Hippo signaling pathway, as well as the p53, Ras-ERK, or WNT networks, to inhibit tumor progression"}, {"pubmed": 19855428, "text": "Lats2 might have an important role in quenching H-Ras-induced transformation."}, {"pubmed": 19937137, "text": "down-regulation of expression in gastric cancer cell is associated with oncogenesis"}, {"pubmed": 20335167, "text": "LATS2 tumor suppressor gene is regulated by tristetraprolin"}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20508983, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20932276, "text": "LATS2 is de-methylated and overexpressed in nasopharyngeal carcinoma and predicts poor prognosis"}, {"pubmed": 21041410, "text": "Data show that Lats2 and ASPP1 shunt p53 to proapoptotic promoters and promote the death of polyploid cells."}, {"pubmed": 21118956, "text": "In response to ultraviolet radiation, Lats2 is phosphorylated by Chk1 and Chk2 at S408."}, {"pubmed": 21233212, "text": "KIBRA associates with and activates Lats (large tumor suppressor) 1 and 2 kinases by stimulating their phosphorylation on the hydrophobic motif"}, {"pubmed": 21245096, "text": "Inactivation of LATS2 is one of the key mechanisms for constitutive activation of YAP, which induces deregulation of MM cell proliferation."}, {"pubmed": 21278236, "text": "Data suggest that defective expression of LATS2 is attributable to FOXP3 defects and may be a major independent determinant of YAP protein elevation in cancer."}, {"pubmed": 21498571, "text": "Results reveal a functional connection between the pRB and Hippo tumor suppressor pathways, and suggest that low levels of LATS2 may undermine the ability of pRB to induce a permanent cell cycle arrest in tumor cells."}, {"pubmed": 21822051, "text": "the results suggest that the Aurora A-Lats1/2-Aurora B axis might be a novel pathway that regulates accurate mitotic progression by ensuring the proper mitotic localization of Lats2."}, {"pubmed": 21832154, "text": "AMOTL2 is as a novel activator of LATS2."}, {"pubmed": 21952048, "text": "Lats2 kinase as a novel regulator of Snail1 protein level, subcellular localization, and thus, activity"}, {"pubmed": 22020941, "text": "MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog"}, {"pubmed": 22098159, "text": "Yap induction mediated by inactivation of Lats is observed in hepatic malignancies."}, {"pubmed": 22286172, "text": "LATS2 represses reprogramming in cells by post-transcriptionally antagonizing TAZ but not YAP, two downstream effectors of the Hippo pathway."}, {"pubmed": 23111389, "text": "LATS2 played important roles in mediating miR-93 functions associated with angiogenesis and metastasis by silencing."}, {"pubmed": 23267128, "text": "Identifying novel kinases which modulate Estrogen Receptor alpha activity is relevant to therapeutics. LATS2 modulates Estrogen Receptor alpha-regulated gene transcription, through direct and/or indirect interactions with Estrogen Receptor alpha."}, {"pubmed": 23852372, "text": "At low cell density, overexpression of the Hippo pathway kinase large tumor suppressor 2 (Lats2) inhibited c-Abl activity."}, {"pubmed": 23886938, "text": "Phosphorylation by Lats2 induces degradation of p21 and promotes apoptosis. Findings describe a novel Lats2-dependent mechanism for induction of cell death in response to severe DNA damage."}, {"pubmed": 24026096, "text": "LATS1 and LATS2 mutations from cancers can lead to loss or reduction of their growth-inhibitory activity"}, {"pubmed": 24101513, "text": "Data indicate that the phosphorylation of Amot130 by LATS1/2 is found to be a key feature that enables it to inhibit Yes-associated protein (YAP) dependent signaling and cell growth."}, {"pubmed": 24106267, "text": "Thus AMOT is a direct substrate of Lats1/2 mediating functions of the Hippo pathway in endothelial cell migration and angiogenesis."}, {"pubmed": 24225952, "text": "These results collectively suggest that the Hippo pathway negatively regulates the actin-binding activity of Amot family members through direct phosphorylation."}, {"pubmed": 24360964, "text": "LATS2 directly interacts with beta-catenin and disrupts beta-catenin iteraction with BCL9."}, {"pubmed": 24735543, "text": "these results indicate that miR-181b promotes proliferation and invasion by targeting LATS2 in ovarian cancer cells."}, {"pubmed": 24743869, "text": "LATS2 over-expression is associated with acute myeloid leukemia."}, {"pubmed": 24779718, "text": "MIR31 significantly suppressed the luciferase activity of mRNA combined with the LATS2 3'-UTR and consequently promoted the translocation of YAP1, a key molecule in the Hippo pathway, into the nucleus"}, {"pubmed": 24976283, "text": "LATS2 protein overexpression is a prognostic indicator for patients diagnosed with colorectal cancer."}, {"pubmed": 24976335, "text": "LATS2 expression level is predictive of survival in patients with resected lung AD. LATS2 may modulate and contribute to tumor growth via different signaling pathways in EGFR mutant and wild-type tumors."}, {"pubmed": 25026211, "text": "NF2 loss-driven derepressed CRL4(DCAF1) promotes activation of YAP by inhibiting hippo pathwat kinases Lats1 and 2 in the nucleus."}, {"pubmed": 25044019, "text": "LATS1 and LATS2 kinases play an important role in the regulation of NS5A function through site-specific post-translational modification and that phosphorylation of Ser/Thr71 is essential for optimal viral genome replication."}, {"pubmed": 25179841, "text": "miR-25 negatively regulated LATS2 expression and promoted OC cell growth and motility."}, {"pubmed": 25391426, "text": "LATS2 was found to negatively regulate NF-kappaB signaling in NSCLC cells."}, {"pubmed": 25482410, "text": "results reported here further support that LATS1/2 act normally as tumor suppressors and loss of their functions contributes to human cancer development"}, {"pubmed": 25658096, "text": "Phosphorylation of S716 NDR/LATS, present only in the longest Kif23 isoform, is required for phosphorylation at S814, revealing phosphorylation at these two sites, and differential regulation of Kif23-14-3-3 interaction for the two Kif23 isoforms."}, {"pubmed": 25782587, "text": "LATS2 could be induced by TNF-alpha and inhibited cell proliferation and invasion by phosphorylating YAP in OSCC cells."}, {"pubmed": 25786116, "text": "Phosphorylation of CHO1 at S716 by Lats2 regulate its centrosomal localization, and that phosphorylated CHO1 interacts with and activates LIMK1 during early mitosis."}, {"pubmed": 25798586, "text": "Mutation in LATS2 gene is associated with malignant peritoneal mesothelioma."}, {"pubmed": 25824045, "text": "miR-25/miR-107-LATS2 axis might play an important role in proliferation and invasion of the gastric cancer cells"}, {"pubmed": 25841306, "text": "Both LATS1 and LATS2 were not related with the clinical variables in mucinous and clear cell carcinoma"}, {"pubmed": 25946971, "text": "Loss of LATS2 expression is associated with lung cancer."}, {"pubmed": 25973055, "text": "our current data indicated a new regulatory mechanism of YAP1 by the LATS2-mediated phosphorylation that was involved in hepatocellular carcinoma tumorigenesis."}, {"pubmed": 26898830, "text": "Characterisation of LATS2 variants uncovers novel insights into the regulation of LATS kinases in Hippo signalling."}, {"pubmed": 26908628, "text": "PVT1 recruits EZH2 to the large tumor suppressor kinase 2 (LATS2) promoter and represses LATS2 transcription."}, {"pubmed": 26934863, "text": "LATS2 was found to have binding sites for miR-135b in the 3'UTR region and results demonstrated that LATS2 is a direct target of miR-135b which regulates its expression in breast cancer cells."}, {"pubmed": 27128293, "text": "Data suggest that, at least using the commercial antibodies used in this study, immunohistochemical staining for NF2 (neurofibromin 2), LATS2 (large tumor suppressor kinase 2), and YAP/TAZ (nuclear translocation of complex of Yes-associated protein [YAP] with transcriptional coactivator with PDZ-binding motif [TAZ]) is not helpful for differential diagnosis of mesothelioma versus a benign proliferation."}, {"pubmed": 27195672, "text": "Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells."}, {"pubmed": 27434182, "text": "The findings reveal a novel signal upstream of PRC2, and provide insight into the crucial role of LATS2 in coordinating the epigenome through regulation of PRC2."}, {"pubmed": 27470365, "text": "overexpression of LATS2 resulted in mobility inhibition in non-small cell lung cancer cell lines A549 and H1299, and reduced protein level of matrix metalloproteinase-2 (MMP-2) and MMP-9."}, {"pubmed": 27730751, "text": "LATS2 as the direct target of miR-372 in prostate cancer cells."}, {"pubmed": 27786336, "text": "LATS1/2 signaling via the Hippo pathway regulates human megakaryocytic differentiation."}, {"pubmed": 28003305, "text": "Genetic data coupled with transcriptomic data allowed the identification of a new malignant pleural mesothelioma (MPM)molecular subgroup, C2(LN), characterized by a co-occurring mutation in the LATS2 and NF2 genes in the same MPM. MPM patients of this subgroup presented a poor prognosis. Coinactivation of LATS2 and NF2 leads to loss of cell contact inhibition between MPM cells"}, {"pubmed": 28068668, "text": "findings reveal a non-canonical (that is, YAP/TAZ-independent) effect of LATS in the regulation of human breast cell fate"}, {"pubmed": 28247446, "text": "The LATS2 is a prognostic biomarker and a tumour metastasis suppressor in hepatocellular carcinoma."}, {"pubmed": 28419554, "text": "STK40 and LATS2 are conserved miR-31 target genes that have roles in regulation of keratinocyte growth and hair follicle biology"}, {"pubmed": 28593479, "text": "Mechanistically, Dnd1 could bind to 3'-UTR of LATS2, the key kinase of Hippo pathway, thus elevating LATS2 mRNA stability and its expression, subsequently leading to phosphorylation of YAP and its cytoplasmic retention."}, {"pubmed": 28775168, "text": "Low LATS2 expression is associated with Liver Cancer."}, {"pubmed": 29145896, "text": "Results identified that miR-31 directly suppressed LATS2 expression, which inactivated TAZ and led to the subsequent action of esophageal squamous cell carcinoma (ESCC) tumorigenicity. Significantly, it was showed that LATS2 and its downstream gene TAZ highly correlated with ESCC progression with poor prognosis."}, {"pubmed": 29183995, "text": "USP9X is a deubiquitylase of the Hippo pathway kinase LATS2 and that the Hippo pathway functions as a downstream signaling cascade that mediates USP9X's tumor-suppressive activity."}, {"pubmed": 29387948, "text": "LATS2 overexpression is associated with chronic myeloid leukemia."}, {"pubmed": 29730476, "text": "Knockdown of Lats1/2 prevented the cytoplasmic delocalization of Yap1/Taz proteins in response to AICAR."}, {"pubmed": 29972924, "text": "The promotor methylation of LATS2 gene may play an important role in the occurrence of oral squamous cell carcinoma."}, {"pubmed": 30010037, "text": "Study shows that LATS2 mRNA expression is remarkably downregulated in breast neoplasm while the protein expression level is absent. The absence of LATS2 protein strongly correlated with promoter hypermethylation and TNM staging."}, {"pubmed": 30266805, "text": "AMOT, AMOTL1, and AMOTL2 enhance Hippo signaling by stimulating LATS1/2 autophosphorylation and by connecting LATS1/2 with both its activator SAV1-MST1/2 and its substrate YAP."}, {"pubmed": 30272278, "text": "Study provides evidence that LATS2 is downregulated in hepatocellular carcinoma (HCC) and may serve as a direct target of miR103 in HCC."}, {"pubmed": 30282996, "text": "MEG3 executed its functions via EZH2 to regulate the downstream target gene LATS2."}, {"pubmed": 30308519, "text": "Knockdown of LATS2 attenuated the suppression of FUS overexpression on hepatocellular carcinoma progression, and LATS2 expression was positively correlated with FUS expression in hepatocellular carcinoma tissues."}, {"pubmed": 30314898, "text": "mechanistic investigation demonstrated that the oncogenic activity of PCAT6 is partially attributable to its repression of LATS2 via association with the epigenetic repressor EZH2 (Enhancer of zeste homolog 2)."}, {"pubmed": 30481780, "text": "miR-650 levels were largely up-regulated in hepatocellular carcinoma (HCC) tissues, and that the increased expression was closely associated with the adverse clinical features of HCC patients. Additionally, the expression of LATS2, which was identified as a direct target of miR-650, can counteract the effects of miR-650 in HCC."}, {"pubmed": 30496488, "text": "LATS2 interacts with ASK1 and increases ASK1-mediated signaling to promote apoptosis and activate the JNK mitogen-activated protein kinase (MAPK)."}, {"pubmed": 30531839, "text": "The function of LATS1/2 in cell growth is cell context dependent."}, {"pubmed": 30551520, "text": "LATS2 is a tumor suppressor of lung cancer via triggering mitochondrial fission and activation of the JNK-Mff signaling pathway."}, {"pubmed": 30592270, "text": "In conclusion, miR492 inhibition may impede the malignant behaviour of retinoblastoma (RB) by directly targeting LATS2. Therefore, targeting this miRNA may be an effective therapeutic method for treating patients with RB"}, {"pubmed": 30593104, "text": "Overexpression of LATS2 could inhibit SCC-25 cell proliferation and induce apoptosis."}, {"pubmed": 30671453, "text": "Lats1/2-meidiated inhibition of Hippo signaling in BMSCs."}, {"pubmed": 30755404, "text": "LATS2 and YAP1, two major components of the Hippo/YAP signaling pathway, form a negative feedback loop to control YAP1 activity and prevent ovarian cells from malignant transformation."}, {"pubmed": 30771084, "text": "LATS2 inhibits glioma cell proliferation and migration/invasion by inactivating YAP."}, {"pubmed": 30852977, "text": "Low LATS2 expression is associated with the development of esophageal squamous cell carcinoma."}, {"pubmed": 30896861, "text": "Study revealed that LATS2 was downregulated in glioma tissues and cells. Overexpression of LATS2 in glioblastoma cells inhibited cell proliferation, migration and invasion. Expression levels of phosphorylated YAP and tafazzin were increased in cells with LATS2 overexpression. These results indicated that LATS2 is a potential tumor suppressor, and downregulation of LATS2 in glioma may contribute to cancer progression."}, {"pubmed": 30981110, "text": "LATS2 modulated DRP1 expression via the Wnt/beta-catenin pathway."}, {"pubmed": 31097223, "text": "The mRNA levels of LATS2 were markedly decreased in tumor tissues and negatively correlated with DDX11-AS1 expression."}, {"pubmed": 31646563, "text": "MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer."}, {"pubmed": 31646568, "text": "LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1."}, {"pubmed": 31669263, "text": "The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa."}, {"pubmed": 31820862, "text": "downregulated LATS2 expression may predict aggressive biologic behavior and a worse prognosis in non-small cell lung carcinoma"}, {"pubmed": 31848340, "text": "Study reports a kinase activity-independent role of LATS1, but not LATS2, in regulating therapy-induced autophagy in hepatocellular carcinoma (HCC) cells. The results indicate that this scaffolding function of LATS1 plays a critical role in the regulation of autophagy and in therapy response of HCC cells and potentially other cancer type cells."}, {"pubmed": 31990985, "text": "The Histone Methyltransferase G9a Promotes Cholangiocarcinogenesis Through Regulation of the Hippo Pathway Kinase LATS2 and YAP Signaling Pathway."}, {"pubmed": 32157157, "text": "Long noncoding RNA NEAT1 suppresses hepatocyte proliferation in fulminant hepatic failure through increased recruitment of EZH2 to the LATS2 promoter region and promotion of H3K27me3 methylation."}, {"pubmed": 32186675, "text": "The present study suggests that miR-224-3p targets LATS2 and blocks the Hippo-YAP signaling pathway activation, thus preventing the progression of retinoblastoma, which could be a new therapeutic target for retinoblastoma."}, {"pubmed": 32259481, "text": "Lats1/2 Sustain Intestinal Stem Cells and Wnt Activation through TEAD-Dependent and Independent Transcription."}, {"pubmed": 32361707, "text": "Inhibition of MiR-10b Restrains the Migration and Epithelial-Mesenchymal Transition of Lung Cells by Targeting LATS2 via TAZ Pathway."}, {"pubmed": 32423384, "text": "Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer."}, {"pubmed": 32428698, "text": "The overexpression of LATS2 repressed the growth and invasion of ACHN and 786-O cells. circ_0001368 upregulated the LATS2 expression and suppressed ACHN and 786-O cell growth and invasion by sponging miR-492."}, {"pubmed": 32452708, "text": "HTS-Compatible CometChip Enables Genetic Screening for Modulators of Apoptosis and DNA Double-Strand Break Repair."}, {"pubmed": 32458634, "text": "Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population."}, {"pubmed": 32534707, "text": "Hippo pathway and tumoral FOXP3 expression correlate with tumor growth in squamous cell carcinoma of the lung."}, {"pubmed": 32682784, "text": "LINC00689 participates in proliferation, chemoresistance and metastasis via miR-31-5p/YAP/beta-catenin axis in colorectal cancer."}, {"pubmed": 33268767, "text": "Long noncoding RNA HOXA-AS2 functions as an oncogene by binding to EZH2 and suppressing LATS2 in acute myeloid leukemia (AML)."}, {"pubmed": 33368671, "text": "The tumor suppressor LATS2 reduces v-Src-induced membrane blebs in a kinase activity-independent manner."}, {"pubmed": 33414893, "text": "MiR-429 Involves in the Pathogenesis of Colorectal Cancer via Directly Targeting LATS2."}, {"pubmed": 33588913, "text": "A specific tRNA half, 5'tiRNA-His-GTG, responds to hypoxia via the HIF1alpha/ANG axis and promotes colorectal cancer progression by regulating LATS2."}, {"pubmed": 33589592, "text": "Circular RNA circ_103820 suppresses lung cancer tumorigenesis by sponging miR-200b-3p to release LATS2 and SOCS6."}, {"pubmed": 33658690, "text": "Hippo signalling maintains ER expression and ER(+) breast cancer growth."}, {"pubmed": 34181498, "text": "LncRNA MYLK-AS1 acts as an oncogene by epigenetically silencing large tumor suppressor 2 (LATS2) in gastric cancer."}, {"pubmed": 34389720, "text": "The Hippo kinase LATS2 impairs pancreatic beta-cell survival in diabetes through the mTORC1-autophagy axis."}, {"pubmed": 34446703, "text": "MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor."}, {"pubmed": 34459131, "text": "Oncogenic PAX6 elicits CDK4/6 inhibitor resistance by epigenetically inactivating the LATS2-Hippo signaling pathway."}, {"pubmed": 34470573, "text": "Deathly triangle for pancreatic beta-cells: Hippo pathway-MTORC1-autophagy."}, {"pubmed": 34492128, "text": "Pathological significance and prognostic role of LATS2 in prostate cancer."}, {"pubmed": 34699318, "text": "Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer."}, {"pubmed": 34831091, "text": "RASSF1A-Mediated Suppression of Estrogen Receptor Alpha (ERalpha)-Driven Breast Cancer Cell Growth Depends on the Hippo-Kinases LATS1 and 2."}, {"pubmed": 34931960, "text": "MicroRNA miR-4709-3p targets Large Tumor Suppressor Kinase 2 (LATS2) and induces obstructive renal fibrosis through Hippo signaling."}, {"pubmed": 35027733, "text": "The Hippo pathway kinases LATS1 and LATS2 attenuate cellular responses to heavy metals through phosphorylating MTF1."}, {"pubmed": 35054822, "text": "Apoptosis in Type 2 Diabetes: Can It Be Prevented? Hippo Pathway Prospects."}, {"pubmed": 35859006, "text": "LATS kinases and SLUG regulate the transition to advanced stage in aggressive oral cancer cells."}, {"pubmed": 36443313, "text": "Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas."}, {"pubmed": 36515852, "text": "FBXO22 Accelerates Pancreatic Cancer Growth by Deactivation of the Hippo Pathway via Destabilizing LATS2."}, {"pubmed": 36796622, "text": "circPKD2 inhibits the glioma cell proliferation, invasion and glycolytic metabolism through regulating the miR-1278/LATS2 axis."}, {"pubmed": 36990424, "text": "The E3 ubiquitin ligase SCF (FBXW10)-mediated LATS2 degradation regulates angiogenesis and liver metastasis in colorectal cancer."}, {"pubmed": 36990459, "text": "Mir-629 Repressed LATS2 Expression and Promoted the Proliferation of Prostate Cancer Cells."}, {"pubmed": 37207933, "text": "RNF106 aggravates esophageal squamous cell carcinoma progression through LATS2/YAP axis."}, {"pubmed": 38568805, "text": "A LATS2 and ALKBH5 positive feedback loop supports their oncogenic roles."}, {"pubmed": 38652219, "text": "MELK aggravates lung adenocarcinoma by regulating EZH2 ubiquitination and H3K27me3 histone methylation of LATS2."}], "genomic_pos": {"chr": "13", "end": 21061586, "ensemblgene": "ENSG00000150457", "start": 20973036, "strand": -1}, "genomic_pos_hg19": {"chr": "13", "end": 21635686, "start": 21547171, "strand": -1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0000082", "qualifier": "involved_in", "term": "G1/S transition of mitotic cell cycle"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0000082", "pubmed": 12853976, "qualifier": "involved_in", "term": "G1/S transition of mitotic cell cycle"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001827", "qualifier": "involved_in", "term": "inner cell mass cell fate commitment"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001828", "qualifier": "involved_in", "term": "inner cell mass cellular morphogenesis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006468", "pubmed": 10871863, "qualifier": "involved_in", "term": "protein phosphorylation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008104", "qualifier": "involved_in", "term": "protein localization"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0009755", "pubmed": 15131260, "qualifier": "involved_in", "term": "hormone-mediated signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0017015", "qualifier": "involved_in", "term": "regulation of transforming growth factor beta receptor signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0018105", "qualifier": "involved_in", "term": "peptidyl-serine phosphorylation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030216", "qualifier": "involved_in", "term": "keratinocyte differentiation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0035329", "qualifier": "involved_in", "term": "hippo signaling"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035329", "pubmed": [20412773, 35429439], "qualifier": "involved_in", "term": "hippo signaling"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0035329", "qualifier": "involved_in", "term": "hippo signaling"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035556", "pubmed": 10871863, "qualifier": "involved_in", "term": "intracellular signal transduction"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0043065", "qualifier": "involved_in", "term": "positive regulation of apoptotic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045736", "pubmed": 12853976, "qualifier": "involved_in", "term": "negative regulation of cyclin-dependent protein serine/threonine kinase activity"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0046620", "qualifier": "involved_in", "term": "regulation of organ growth"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051301", "qualifier": "involved_in", "term": "cell division"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060070", "qualifier": "involved_in", "term": "canonical Wnt signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0090090", "pubmed": 20412773, "qualifier": "involved_in", "term": "negative regulation of canonical Wnt signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1900181", "qualifier": "involved_in", "term": "negative regulation of protein localization to nucleus"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0000922", "qualifier": "is_active_in", "term": "spindle pole"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0000922", "pubmed": 12853976, "qualifier": "located_in", "term": "spindle pole"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": 10673337, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0005634", "pubmed": 10673337, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": 35429439, "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "pubmed": 30865227, "qualifier": "located_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0034451", "qualifier": "located_in", "term": "centriolar satellite"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0004674", "qualifier": "enables", "term": "protein serine/threonine kinase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004674", "pubmed": [10871863, 30865227, 35429439], "qualifier": "enables", "term": "protein serine/threonine kinase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0004674", "qualifier": "enables", "term": "protein serine/threonine kinase activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [16413547, 18158288, 19739119, 20303269, 24255178, 24682284, 25026211, 25438054, 27107012, 28514442, 30865227, 32707033], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0005524", "pubmed": 10871863, "qualifier": "enables", "term": "ATP binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046872", "qualifier": "enables", "term": "metal ion binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0106310", "qualifier": "enables", "term": "protein serine kinase activity"}]}, "homologene": {"genes": [[7955, 567674], [8364, 100124721], [9031, 418949], [9598, 452466], [9606, 26524], [9615, 477343], [10090, 50523], [10116, 305922]], "id": 56678}, "interpro": [{"desc": "Protein kinase domain", "id": "IPR000719", "short_desc": "Prot_kinase_dom"}, {"desc": "AGC-kinase, C-terminal", "id": "IPR000961", "short_desc": "AGC-kinase_C"}, {"desc": "Serine/threonine-protein kinase, active site", "id": "IPR008271", "short_desc": "Ser/Thr_kinase_AS"}, {"desc": "UBA-like superfamily", "id": "IPR009060", "short_desc": "UBA-like_sf"}, {"desc": "Protein kinase-like domain superfamily", "id": "IPR011009", "short_desc": "Kinase-like_dom_sf"}, {"desc": "Ubiquitin-associated domain", "id": "IPR015940", "short_desc": "UBA"}, {"desc": "Protein kinase, ATP binding site", "id": "IPR017441", "short_desc": "Protein_kinase_ATP_BS"}, {"desc": "Protein kinase, C-terminal", "id": "IPR017892", "short_desc": "Pkinase_C"}], "ipi": "IPI00016690", "map_location": "13q12.11", "name": "large tumor suppressor kinase 2", "other_names": ["LATS (large tumor suppressor, Drosophila) homolog 2", "LATS, large tumor suppressor, homolog 2", "kinase phosphorylated during mitosis protein", "large tumor suppressor homolog 2", "serine/threonine kinase KPM", "serine/threonine-protein kinase LATS2", "serine/threonine-protein kinase kpm", "warts-like kinase"], "pantherdb": {"HGNC": "6515", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1354386", "ortholog_type": "LDO", "panther_family": "PTHR24356", "taxid": 10090, "uniprot_kb": "Q7TSJ6"}, {"RGD": "1305906", "ortholog_type": "LDO", "panther_family": "PTHR24356", "taxid": 10116, "uniprot_kb": "A0A0G2K4A8"}, {"Ensembl": "ENSGALG00000053657", "ortholog_type": "LDO", "panther_family": "PTHR24356", "taxid": 9031, "uniprot_kb": "A0A3Q2UI52"}, {"ZFIN": "ZDB-GENE-050119-6", "ortholog_type": "LDO", "panther_family": "PTHR24356", "taxid": 7955, "uniprot_kb": "A0A2R8QF71"}, {"WormBase": "WBGene00007047", "ortholog_type": "O", "panther_family": "PTHR24356", "taxid": 6239, "uniprot_kb": "O45797"}, {"FlyBase": "FBgn0011739", "ortholog_type": "O", "panther_family": "PTHR24356", "taxid": 7227, "uniprot_kb": "Q9VA38"}, {"dictyBase": "DDB_G0290859", "ortholog_type": "O", "panther_family": "PTHR24356", "taxid": 352472, "uniprot_kb": "Q54FH3"}, {"dictyBase": "DDB_G0278457", "ortholog_type": "O", "panther_family": "PTHR24356", "taxid": 352472, "uniprot_kb": "Q54Y26"}], "uniprot_kb": "Q9NRM7"}, "pathway": {"kegg": [{"id": "hsa04390", "name": "Hippo signaling pathway - Homo sapiens (human)"}, {"id": "hsa04392", "name": "Hippo signaling pathway - multiple species - Homo sapiens (human)"}], "pid": {"id": "ar_pathway", "name": "Coregulation of Androgen receptor activity"}, "reactome": [{"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-2028269", "name": "Signaling by Hippo"}], "wikipathways": [{"id": "WP4239", "name": "Epithelial to mesenchymal transition in colorectal cancer"}, {"id": "WP4533", "name": "Transcription co-factors SKI and SKIL protein partners"}, {"id": "WP4537", "name": "Hippo-Yap signaling pathway"}, {"id": "WP4540", "name": "Pathways Regulating Hippo Signaling"}, {"id": "WP4541", "name": "Hippo-Merlin Signaling Dysregulation"}, {"id": "WP4542", "name": "Overview of leukocyte-intrinsic Hippo pathway functions"}]}, "pdb": "4ZRI", "pfam": ["PF00069", "PF00433"], "pharmgkb": "PA30302", "pharos": {"target_id": 18370, "tdl": "Tchem"}, "prosite": ["PS50011", "PS50030", "PS51285"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF263991", "relationship": "is"}, {"id": "GNF263992", "relationship": "is"}, {"id": "GNF263993", "relationship": "is"}, {"id": "GNF263994", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": [{"id": "GNF164466", "relationship": "similar to"}, {"id": "GNF164701", "relationship": "similar to"}], "GNF_hs-Origene": {"id": "GNF046209", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF085415", "relationship": "is"}, {"id": "GNF085416", "relationship": "is"}, {"id": "GNF085417", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF050762", "relationship": "is"}, {"id": "GNF055524", "relationship": "is"}, {"id": "GNF060172", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF071751", "relationship": "is"}, {"id": "GNF071752", "relationship": "is"}], "GNF_hs-pkinase_IDT-siRNA": [{"id": "GNF165908", "relationship": "is"}, {"id": "GNF165909", "relationship": "is"}, {"id": "GNF165910", "relationship": "is"}, {"id": "GNF165911", "relationship": "is"}], "Invitrogen_IVTHSSIPKv2": [{"id": "GNF324218", "relationship": "is"}, {"id": "GNF324219", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF093012", "relationship": "is"}, {"id": "GNF132710", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000013.11", "NC_060937.1"], "protein": ["NP_055387.2", "XP_005266399.1", "XP_011533344.1", "XP_016876030.1", "XP_016876031.1", "XP_047286222.1", "XP_047286223.1", "XP_054230417.1", "XP_054230418.1", "XP_054230419.1", "XP_054230420.1", "XP_054230421.1", "XP_054230422.1", "XP_054230423.1"], "rna": ["NM_014572.3", "XM_005266342.1", "XM_011535042.3", "XM_017020541.2", "XM_017020542.2", "XM_047430266.1", "XM_047430267.1", "XM_054374442.1", "XM_054374443.1", "XM_054374444.1", "XM_054374445.1", "XM_054374446.1", "XM_054374447.1", "XM_054374448.1"], "translation": [{"protein": "XP_054230423.1", "rna": "XM_054374448.1"}, {"protein": "XP_005266399.1", "rna": "XM_005266342.1"}, {"protein": "NP_055387.2", "rna": "NM_014572.3"}, {"protein": "XP_054230418.1", "rna": "XM_054374443.1"}, {"protein": "XP_047286222.1", "rna": "XM_047430266.1"}, {"protein": "XP_047286223.1", "rna": "XM_047430267.1"}, {"protein": "XP_011533344.1", "rna": "XM_011535042.3"}, {"protein": "XP_054230419.1", "rna": "XM_054374444.1"}, {"protein": "XP_054230422.1", "rna": "XM_054374447.1"}, {"protein": "XP_054230420.1", "rna": "XM_054374445.1"}, {"protein": "XP_054230417.1", "rna": "XM_054374442.1"}, {"protein": "XP_016876030.1", "rna": "XM_017020541.2"}, {"protein": "XP_054230421.1", "rna": "XM_054374446.1"}, {"protein": "XP_016876031.1", "rna": "XM_017020542.2"}]}, "reporter": {"GNF1H": ["gnf1h02724_s_at", "gnf1h07549_at"], "HG-U133_Plus_2": ["223379_s_at", "223380_s_at", "227013_at", "230348_at"], "HTA-2_0": "TC13000463.hg.1", "HuEx-1_0": ["2681980", "3504526"], "HuGene-1_1": "7970498", "HuGene-2_1": "16777259"}, "retired": 95108, "summary": "This gene encodes a serine/threonine protein kinase belonging to the LATS tumor suppressor family. The protein localizes to centrosomes during interphase, and early and late metaphase. It interacts with the centrosomal proteins aurora-A and ajuba and is required for accumulation of gamma-tubulin and spindle formation at the onset of mitosis. It also interacts with a negative regulator of p53 and may function in a positive feedback loop with p53 that responds to cytoskeleton damage. Additionally, it can function as a co-repressor of androgen-responsive gene expression. [provided by RefSeq, Jul 2008].", "symbol": "LATS2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1334331"}, "unigene": "Hs.78960", "uniprot": {"Swiss-Prot": "Q9NRM7"}, "wikipedia": {"url_stub": "LATS2"}}